The Firebrick Board is committed to achieving the highest standards of corporate governance. The Board guides and monitors the company’s activities on behalf of the shareholders.
|Anti-Bribery and Anti-Corruption Policy|
|Audit and Risk Committee Charter|
23 November 2022 View
|Continuous Disclosure Policy|
|Corporate Code of Conduct|
|Corporate Governance Statement||
23 August 2022 View
|Cyber Security Commitment|
|Directors' Skills Matrix||
20 July 2022 View
|Nomination Committee Charter|
|Performance Evaluation Policy|
|Remuneration Committee Charter|
|Risk Management Policy|
|Shareholder Communications Strategy|
|Whistleblower Protection Policy|
Your right to elect to receive documents electronically or in hard copy
Firebrick Pharma will not send a hard copy of meeting documents unless a shareholder requests a copy to be mailed.
We encourage all shareholders to provide an email address so that we can provide investor communications electronically when they become available online, which includes items such as meeting documents and annual reports.
Shareholders can still elect to receive some or all of their communications in hard copy or electronic form or elect not to receive certain documents such as annual reports.
To review your communications preferences, or sign up to receive your shareholder communications via email, please update your communication preferences at https://investor.automic.com.au
If you are a shareholder and would like a hard copy of a communication, need further information about the options available to you or have questions about your holding, visit https://investor.automic.com.au/ or contact our share registry:
- Telephone (within Australia): 1300 288 664
- Telephone (outside Australia): +61 2 9698 5414
- Email: firstname.lastname@example.org
- Website: https://investor.automic.com.au